Stefania Scala

10PUBLICATIONS
59CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 28, 2026
CXCR4, CXCR7 and PBRM1 are responsible for everolimus and cabozantinib resistance in human renal cancer cells.

Federica Auletta, Caterina Ieranò, Dario Guido Di Febbraro

|Aug 21, 2024
KIR2DL2/DL3+NKs and Helios+Tregs in Peripheral Blood Predict Nivolumab Response in Patients with Metastatic Renal Cell Cancer.

Sara Santagata, Anna Maria Trotta, Crescenzo D'Alterio

|May 04, 2024
Targeting CXCR4 impaired T regulatory function through PTEN in renal cancer patients.

Sara Santagata, Giuseppina Rea, Anna Maria Bello

|Mar 29, 2023
Oligo-Metastatic Cancers: Putative Biomarkers, Emerging Challenges and New Perspectives.

Alessandro Ottaiano, Mariachiara Santorsola, Luisa Circelli

|Apr 12, 2022
Biological Role of Tumor/Stromal CXCR4-CXCL12-CXCR7 in MITO16A/MaNGO-OV2 Advanced Ovarian Cancer Patients.

Crescenzo D'Alterio, Anna Spina, Laura Arenare

|Mar 05, 2022
In PD-1+ human colon cancer cells NIVOLUMAB promotes survival and could protect tumor cells from conventional therapies.

Caterina Ieranò, Dario Righelli, Crescenzo D'Alterio

Pageof 2

Frequent Collaborators

4 joint publications

Fabiana Tatangelo

4 joint publications

Alessandro Ottaiano

3 joint publications

Annabella Di Mauro

3 joint publications

Paolo Delrio